Kezar Life Sciences's market cap is currently ―. The company's EPS TTM is $-1.403; its P/E ratio is -0.57; Kezar Life Sciences is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 7.00M	-	-	-	$ 0.00
Gross Profit	$ 7.00M	-	-	-	-
EBIT	$ -22.71M	$ -23.92M	$ -21.83M	$ -20.03M	$ -17.54M
EBITDA	$ -24.14M	$ -25.43M	$ -23.22M	$ -21.62M	$ -17.08M
Net Income Common Stockholders	$ -23.10M	$ -24.31M	$ -22.20M	$ -18.18M	$ -17.85M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 218.21M	$ 236.59M	$ 257.67M	$ 276.56M	$ 290.38M
Total Assets	$ 249.33M	$ 263.38M	$ 284.18M	$ 299.57M	$ 304.77M
Total Debt	$ 19.55M	$ 20.15M	$ 20.72M	$ 21.26M	$ 13.32M
Net Debt	$ -198.65M	$ -216.44M	$ -236.95M	$ -255.30M	$ -277.07M
Total Liabilities	$ 33.33M	$ 31.10M	$ 31.69M	$ 29.70M	$ 21.58M
Stockholders Equity	$ 215.99M	$ 232.28M	$ 252.49M	$ 269.87M	$ 283.19M
Cash Flow	-
Free Cash Flow	$ -20.34M	$ -22.98M	$ -21.16M	$ -16.23M	$ -16.96M
Operating Cash Flow	$ -20.20M	$ -21.60M	$ -20.86M	$ -15.88M	$ -16.36M
Investing Cash Flow	$ 18.57M	$ 13.20M	$ 16.39M	$ -8.66M	$ -24.71M
Financing Cash Flow	$ 43.00K	$ 382.00K	$ 154.00K	$ 506.00K	$ 185.00K

Currency in USD

Kezar Life Sciences Earnings and Revenue History

Income Statement >

Kezar Life Sciences Debt to Assets

Balance Sheet >

Kezar Life Sciences Cash Flow

Cash Flow >

Kezar Life Sciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing